|
Volumn 86, Issue 11, 2001, Pages 5294-5300
|
123I isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer: Comparison with post 131I therapy whole body scanning
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IODINE 123;
DIAGNOSTIC AGENT;
RADIOACTIVE IODINE;
RADIOPHARMACEUTICAL AGENT;
THYROGLOBULIN;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BONE METASTASIS;
CANCER DIAGNOSIS;
CERVICAL LYMPH NODE;
CHILD;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED STUDY;
DIAGNOSTIC IMAGING;
DIAGNOSTIC PROCEDURE;
DIAGNOSTIC VALUE;
DRUG UPTAKE;
FEMALE;
FOLLOW UP;
HUMAN;
LUNG METASTASIS;
LYMPH NODE METASTASIS;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
THYROID CANCER;
TREATMENT OUTCOME;
WHOLE BODY SCINTISCANNING;
CLINICAL TRIAL;
COMPARATIVE STUDY;
METABOLISM;
MIDDLE AGED;
SCINTISCANNING;
THYROID TUMOR;
WHOLE BODY COUNTING;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
FEMALE;
HUMANS;
IODINE RADIOISOTOPES;
MALE;
MIDDLE AGED;
RADIOPHARMACEUTICALS;
THYROGLOBULIN;
THYROID NEOPLASMS;
WHOLE-BODY COUNTING;
|
EID: 85047682180
PISSN: 0021972X
EISSN: None
Source Type: Journal
DOI: 10.1210/jcem.86.11.8030 Document Type: Article |
Times cited : (41)
|
References (26)
|